The promise of precision medicine is that it could offer better health outcomes by targeting patients’ genetic and biochemical make-up to pinpoint, predict, prevent and treat diseases. Can it deliver on this?
Hear world-renowned thinkers explore some of the key issues around precision medicine. They analyse the realities of disease prediction, economics, ethics, clinical applications and the balance between the personal and the public benefit.
Featuring:
- Professor Sandro Galea, Boston University
- Professor Sarah Wordsworth, University of Oxford
- Professor Christopher Semsarian, University of Sydney
- Associate Professor Ainsley Newson, University of Sydney
- (Chair) Professor Robyn Ward, University of Sydney
This conversation was recorded on Wednesday 2 October, 2019 at the University of Sydney. For details about the event, speaker lineup and more, visit the website: http://bit.ly/2m7Ja6Y
